The PlexusDx Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence individual response to GLP-1 therapy
And unlike existing addiction medications, which are prescribed by specialists and remain vastly underused, GLP-1 drugs are already prescribed at enormous scale by primary care doctors
Since January 1st, the total number of filings has increased by 478, reflecting a steady rise in claims
As with other GH-axis compounds, sustained use is associated with reported water retention, joint aches, tingling, and reduced insulin sensitivity
Clinical data shows that approximately 70% of weight lost returns within one year of discontinuing these medications, suggesting that sustained therapy may be necessary for durable results